News and Events
Most recent press releases. For a complete list, see here.
Topas Therapeutics Raises €22 Million (~USD 26 Million) in Series B Financing
Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief Executive Officer
Topas Therapeutics Announces First Patient Enrolled in Phase 1 Trial with TPM203 in Pemphigus Vulgaris
The next upcoming event. For a complete list, see here.